Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.23 - $0.35 $11,339 - $17,255
-49,300 Reduced 29.72%
116,600 $33,000
Q1 2022

May 16, 2022

BUY
$0.28 - $0.68 $7,728 - $18,768
27,600 Added 19.96%
165,900 $58,000
Q4 2021

Feb 14, 2022

BUY
$0.6 - $1.04 $24,180 - $41,912
40,300 Added 41.12%
138,300 $83,000
Q3 2021

Nov 15, 2021

SELL
$0.99 - $1.38 $108,306 - $150,972
-109,400 Reduced 52.75%
98,000 $101,000
Q2 2021

Aug 11, 2021

SELL
$1.14 - $1.87 $295,944 - $485,452
-259,600 Reduced 55.59%
207,400 $261,000
Q1 2021

May 17, 2021

BUY
$1.34 - $3.53 $572,582 - $1.51 Million
427,300 Added 1076.32%
467,000 $831,000
Q3 2019

Nov 14, 2019

BUY
$0.97 - $1.77 $28,227 - $51,507
29,100 Added 274.53%
39,700 $47,000
Q2 2019

Aug 14, 2019

SELL
$0.96 - $1.89 $10,944 - $21,546
-11,400 Reduced 51.82%
10,600 $13,000
Q1 2019

May 15, 2019

BUY
$1.76 - $3.73 $38,720 - $82,060
22,000 New
22,000 $39,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.